CARDIOLIPIN IGA EIA TEST SYSTEM— 510(k) K952522
Substantially EquivalentImmunoprobe, Inc.
FDA 510(k) clearance K952522 for CARDIOLIPIN IGA EIA TEST SYSTEM, Substantially Equivalent on 1996-02-09. Applicant: Immunoprobe, Inc..
Clearance details
- Applicant
- Immunoprobe, Inc.
- Product code
- Code MID
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Washington, D.C., DC, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.